IP Verse

Hyaluronic Acid Gels Crosslinked By Sodium Trimetaphosphate - EP2994090B1

PatentPatent Analysis

EP2994090

ALLERGAN INDUSTRIE
Application Number
EP13752667A
Filing Date
May 8, 2013
Status
Opposition Rejected
Dec 22, 2023
Grant Date
Dec 6, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3256097B1
EP3138586B1
EP2674147B1

Bibliography

The patent EP2994090B1 was granted to Allergan Industrie on Dec 6, 2017 following the initial filing on May 8, 2013 under the application number EP13752667A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LABORATOIRES VIVACYSep 5, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents